MedTrace Logo

A Study to Collect Data About Analgesia in Patients With Bone Metastasis

NCT02774213 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2019-08-19

Study results available
· View outcomes & findings →

Summary

Up to 180 patients with bone metastasis and requiring analgesic treatment will be followed during 4 to 10 weeks. All patients will continue to receive their cancer therapeutic treatments and be treated for pain relief exactly as they would normally be by the Investigator based on their needs. During their regular visits to the Investigator, patients will complete questionnaires and Clinical Pain Assessments.

Conditions

  • Bone Metastasis

Interventions

OTHER

Questionnaires completion

OTHER

Clinical Pain Assessments

Sponsors & Collaborators

  • Tools4Patient

    lead OTHER

Principal Investigators

  • Alvaro Pereira · Tools4Patient

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-04-28
Completion
2017-04-28

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02774213 on ClinicalTrials.gov